8 February 2020 — Internationalist 360°
Cuba’s biotechnological industry developed the antiviral recombinant Interferon alpha 2B (IFNrec) to combat viral infections affecting patients with HIV, hepatitis B and C,recurrent respiratory papillomatosis, condyloma acuminatum, as well as various types of cancer. Now, China’s National Health Commission selected IFNrec to fight the coronavirus (2019-nCoV) outbreak, which appeared in the city of Wuhan at the end of last year and as of Friday had left 722 deaths and more than 34 thousand people infected.
View original post 360 more words